Cementless total hip arthroplasty for osteonecrosis of the femoral head after allogenic bone marrow transplantation.
From 1998 until 2004, we performed 26 consecutive cementless total hip arthoplasties in 15 patients who had developed advanced avascular necrosis of the femoral head after allogenic bone marrow transplantation. The average age at transplantation was 31.1 years, and the mean age at implantation was 33.6 years. Follow-up period ranged from 2 to 8 years with an average of 56.4 months. The mean D'Aubigne-Postel score improved from 7.5 points preoperatively to 17 points postoperatively. The overall result was excellent in 92.3%, good in 3.8%, and fair in 3.8% of cases. There were no radiological signs of components loosening and no severe complications. Cementless total hip arthroplasty appears as a favorable alternative for the treatment of avascular necrosis of the femoral heads after allogenic bone marrow transplantation.
Petsatodis
George E
GE
1st Orthopedic Department of the Aristotle University of Thessaloniki, G.Papanikolaou Hospital, Thessaloniki, Greece.
Antonarakos
Petros D
PD
Christodoulou
Anastasios G
AG
Pappas
Labros S
LS
Pournaras
John D
JD
D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D019644:Arthroplasty, Replacement, Hip; D001843:Bone Cements; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D005271:Femur Head Necrosis / Q000209:etiology / Q000601:surgery*; D005938:Glucocorticoids / Q000009:adverse effects*; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000209:etiology; D006402:Hematologic Diseases / Q000188:drug therapy / Q000601:surgery*; D006801:Humans; D008875:Middle Aged; D014184:Transplantation, Homologous; D055815:Young Adult
D000970:Antineoplastic Agents; D001843:Bone Cements; D005938:Glucocorticoids